In these changing times, the concept of Open Innovation is one that we at AstraZeneca have fully embraced.
By sharing new ideas and enabling scientific innovation to cross boundaries between companies, academia, government and non-profit organizations, we can accelerate new ideas into innovative medicines.
An Open Innovation discussion at BIO
I will discuss the importance that AstraZeneca places on Open Innovation today at this year’s BIO International Convention. An interactive session will include a panel discussion and presentations of cases studies of notable Open Innovation success stories.
{iframe}http://www.biotech-now.org/health/2013/04/bio-2013-open-innovation-and-biopharmaceutical-rd?utm_source=Feedburner&utm_medium=feed&utm_campaign=Feed%3A+BiotechNow+(BIOtech+Now)&utm_term=RSS+Subscription#{/iframe}